两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-006359 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-006357 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-006358 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-001187 Act: 33 Size: 1 KB 网页链接
$Onconova医疗(ONTX)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001104659-20-062699 Act: 33 Size: 288 KB 网页链接
$Onconova医疗(ONTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-20-062608 Act: 34 Size: 5 MB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-061646 Act: 34 Size: 85 KB 网页链接
$Onconova医疗(ONTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-20-059137 Act: 34 Size: 40 KB 网页链接
$Onconova医疗(ONTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-20-059138 Act: 34 Size: 58 KB 网页链接
$Onconova医疗(ONTX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-20-051099 Act: 33 Size: 347 KB 网页链接